Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression

International Journal of Molecular Medicine

Volumn 26, Issue 3, 2010, Pages 379-385

  Cheng, Chun Yuan ^a,b   Su, Chin Cheng ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Calreticulin; Caspase 12; GADD153; J5 cells; Tanshinone IIA

Indexed keywords

ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CALRETICULIN; CASPASE 12; CASPASE INHIBITOR; CYSTEINE PROTEINASE INHIBITOR; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HERBACEOUS AGENT; PEPTIDE CHLOROMETHYL KETONE; PHENANTHRENE DERIVATIVE; TANSHINONE;

ANIMAL; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; HUMAN; LIVER NEOPLASMS; MALE; METABOLISM; MITOCHONDRION; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CALRETICULIN; CARCINOMA, HEPATOCELLULAR; CASPASE 12; CASPASE INHIBITORS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE PROTEINASE INHIBITORS; DITERPENES, ABIETANE; DRUGS, CHINESE HERBAL; HUMANS; LIVER NEOPLASMS; MALE; MITOCHONDRIA; PHENANTHRENES; TRANSCRIPTION FACTOR CHOP;

EID: 77956671604     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000476     Document Type: Article

References (25)

1. Bosch FX, Ribes J, Cléries R and Díaz M: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9: 191-211, 2005.
2. Statistics of Causes of Death, 2007. Department of Health, Executive Yuan, Taipei, Taiwan, R.O.C, p34-46, 2008.
3. Leung TW and Johnson PJ: Systemic therapy for hepatocellular carcinoma. Semin Oncol 28: 514-520, 2001.
4. Oyadomari S and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389, 2004. (Pubitemid 38489416)
5. Che AJ, Zhang JY, Li CH, Chen XF, Hu ZD and Chen XG: Separation and determination of active components in Radix Salviae miltiorrhizae and its medicinal preparations by nonaqueous capillary electrophoresis. J Sep Sci 27: 569-575, 2004.
6. Zhou L, Zuo Z and Chow MS: Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-1359, 2005.
7. Lin R, Wang WR, Liu JT, Yang GD and Han CJ: Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J Ethnopharmacol 108: 217-222, 2006. (Pubitemid 44635028)
8. Wang AM, Sha SH, Lesniak W and Schacht J: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841, 2003.
9. Jang SI, Kim HJ, Kim YJ, Jeong SI and You YO: Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 542: 1-7, 2006.
10. Li W, Li J, Ashok M, Wu R, Chen D, Yang L, Yang H, Tracey KJ, Wang P, Sama AE and Wang H: A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 78: 3856-3864, 2007.
11. Liu JJ, Lin DJ, Liu PQ, Huang M, Li XD and Huang RW: Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci 13: 813-823, 2006.
12. Su CC and Lin YH: Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med 22: 357-361, 2008.
13. Su CC, Chen GW, Kang JC and Chan MH: Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med 74: 1357-1362, 2008.
14. Chiu TL and Su CC: Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med 25: 231-236, 2010.
15. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF and Zhang J: Growth inhibition and apoptosis induction of tanshinone IIA on human hepatocellular carcinoma cells. World J Gastroenterol 10: 2024-2028, 2004. (Pubitemid 39106951)
16. Zhai XM, He SX, Ren MD, Chen JH, Wang ZL, Han M and Hou HL: Effect of Tanshinone II A on expression of EGF and EGFR in hepatocellular carcinoma cell line SMMC-7721. Zhejiang Da Xue Xue Bao Yi Xue Ban. 38: 163-169, 2009.
17. Lee WY, Liu KW and Yeung JH: Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells. Cancer Lett 285: 46-57, 2009.
18. Mossman T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
19. Su CC and Lin YH: Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-α in colon cancer cells in vitro and in vivo. Int J Mol Med 22: 847-851, 2008.
20. Bradford MM: A rapid and sensitive method for the quantization of microgram quantities of protein using the principle of proteindye binding. Anal Biochem 72: 248-254, 1976.
21. Su CC, Chen GW and Lin JG: Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells. Int J Mol Med 22: 613-618, 2008.
22. Lin SS, Huang HP, Yang JS, Wu JY, Hsia TC, Lin CC, Lin CW, Kuo CL, Gibson Wood W and Chung JG: DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway. Cancer Lett 272: 77-90, 2008.
23. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Metivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L and Kroemer G: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54-61, 2007. (Pubitemid 46067386)
24. Clarke C and Smyth MJ: Calreticulin exposure increases cancer immunogenicity. Nat Biotechnol 25: 192-193, 2007.
25. Apetoh L, Ghiringhelli F and Zitvogel L: [Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy]. Med Sci (Paris) 23: 257-258, 2007.